Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

NCT ID: NCT05177952

Last Updated: 2024-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to compare the effectiveness of the current Multiple Sclerosis standard of care exercise recommendations to low-load resistance training with blood flow restriction on functional outcomes, strength, muscle size, and neuromuscular control in Multiple Sclerosis patients. This study involves completing 2 training sessions per week for 12 weeks as well as pre- and post-training assessment visits for a total of 29 visits over 14 weeks. All visits will be on UCF's campus with a member of the research team.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Training Study Multiple Sclerosis Blood Flow Restriction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized between group parallel
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Participants and Investigators will be aware of treatment groups

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blood Flow Restriction

The BFR group will complete 1 set of 30 (1 x 30) at 30% of their 1 repetition maximum for leg press, leg extension, leg curl, chest press, seated row, and shoulder press completed on exercise machines with 2 minutes between exercises.

Group Type EXPERIMENTAL

Blood Flow Restriction

Intervention Type OTHER

Resistance training with BFR

Standard of Care

The standard of care group will complete 1 set of 8-12 repetitions at 60-80% of their 1 repetition maximum for leg press, leg extension, leg curl, chest press, seated row, and shoulder press completed on exercise machines with 2 minutes between exercises.

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Resistance Training with no BFR

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Flow Restriction

Resistance training with BFR

Intervention Type OTHER

Standard of Care

Resistance Training with no BFR

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Females between the ages of 18 to 55
* Diagnosed with Multiple Sclerosis
* Expanded Disability Status Score of 0 to 6.5
* Able to walk 10 meters without assistance
* Are willing to come in for all 29 testing visits over 14 weeks

Exclusion Criteria

* No other known cardiovascular, pulmonary, metabolic, muscular, and/or coronary heart disease
* Multiple Sclerosis relapse in the past 30 days
* Are not currently undergoing a rehabilitation protocol
* Are not currently seeking medical care for a chronic condition that could limit exercise capacity other than multiple sclerosis
* Are not currently pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AdventHealth

OTHER

Sponsor Role collaborator

University of Central Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ethan Hill, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Central Florida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Central Florida

Orlando, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00003396: BFR MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Periodization and Parkinson's Disease
NCT07141849 RECRUITING NA